The latest closing stock price for Actuate Therapeutics as of May 30, 2025 is 12.00.
An investor who bought $1,000 worth of Actuate Therapeutics stock at the IPO in 2024 would have $394 today, roughly 0 times their original investment - a 39.37% compound annual growth rate over 1 years.
The all-time high Actuate Therapeutics stock closing price was 12.00 on May 30, 2025.
The Actuate Therapeutics 52-week high stock price is 11.99, which is -0.1% above the current share price.
The Actuate Therapeutics 52-week low stock price is 5.51, which is 54.1% below the current share price.
The average Actuate Therapeutics stock price for the last 52 weeks is 8.27.
An investor who bought $1,000 worth of Actuate Therapeutics stock at the IPO in 2024 would have $394 today, roughly 0 times their original investment - a 39.37% compound annual growth rate over 1 years.
The all-time high Actuate Therapeutics stock closing price was 12.00 on May 30, 2025.
The Actuate Therapeutics 52-week high stock price is 11.99, which is -0.1% above the current share price.
The Actuate Therapeutics 52-week low stock price is 5.51, which is 54.1% below the current share price.
The average Actuate Therapeutics stock price for the last 52 weeks is 8.27.